Turano S, Conforti S. Long-term survival in a patient with metastatic HER2+ breast cancer undergoing lapatinib-based therapy for 6 years: Lunga sopravvivenza in una paziente con carcinoma mammario HER2-positivo metastatico in terapia da sei anni con lapatinib. AboutOpen [Internet]. 2018 Sep. 10 [cited 2024 Nov. 23];4(1):8-10. Available from: https://journals.aboutscience.eu/index.php/aboutopen/article/view/7